Cargando…
Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
Autores principales: | Åsberg, Anders, Hovd, Markus, Kjellevold, Stig Arne, Stenehjem, Aud-E., Wien, Tale Norbye, Broch, Lars Ulrik, Reier-Nielsen, Morten, Qvale, Tor Hatlestad, Marti, Hans-Peter, Heldal, Kristian, Bitter, Jan, Hagelsteen Kvien, Elisabeth, Vaage, John Torgils, Lund-Johansen, Fridtjof, Midtvedt, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519284/ https://www.ncbi.nlm.nih.gov/pubmed/37496122 http://dx.doi.org/10.1097/TP.0000000000004732 |
Ejemplares similares
-
Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023) -
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023) -
Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
por: Midtvedt, Karsten, et al.
Publicado: (2021) -
The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
por: Hammer, Hilde Berner, et al.
Publicado: (2011) -
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
por: König, Marton, et al.
Publicado: (2022)